{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:47:43Z","timestamp":1794541663911,"version":"4.9.1"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Human umbilical cord mesenchymal stem cells (HUC-MSCs) present in the umbilical cord tissue are self-renewing and multipotent. They can renew themselves continuously and, under certain conditions, differentiate into one or more cell types constituting human tissues and organs. HUC-MSCs differentiate, among others, into osteoblasts, chondrocytes, and adipocytes and have the ability to secrete cytokines. The possibility of noninvasive harvesting and low immunogenicity of HUC-MSCs give them a unique advantage in clinical applications. In recent years, HUC-MSCs have been widely used in clinical practice, and some progress has been made in their use for therapeutic purposes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Main body<\/jats:title>\n                <jats:p>This article describes two aspects of the clinical therapeutic effects of HUC-MSCs. On the one hand, it explains the benefits and mechanisms of HUC-MSC treatment in various diseases. On the other hand, it summarizes the results of basic research on HUC-MSCs related to clinical applications. The first part of this review highlights several functions of HUC-MSCs that are critical for their therapeutic properties: differentiation into terminal cells, immune regulation, paracrine effects, anti-inflammatory effects, anti-fibrotic effects, and regulating non-coding RNA. These characteristics of HUC-MSCs are discussed in the context of diabetes and its complications, liver disease, systemic lupus erythematosus, arthritis, brain injury and cerebrovascular diseases, heart diseases, spinal cord injury, respiratory diseases, viral infections, and other diseases. The second part emphasizes the need to establish an HUC-MSC cell bank, discusses tumorigenicity of HUC-MSCs and the characteristics of different in vitro generations of these cells in the treatment of diseases, and provides technical and theoretical support for the clinical applications of HUC-MSCs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>HUC-MSCs can treat a variety of diseases clinically and have achieved good therapeutic effects, and the development of HUC-MSC assistive technology has laid the foundation for its clinical application.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13287-020-02011-z","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T07:03:23Z","timestamp":1606806203000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":230,"title":["What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment?"],"prefix":"10.1186","volume":"11","author":[{"given":"Qixin","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"issue":"6","key":"2011_CR1","first-page":"4969","volume":"18","author":"J Li","year":"2018","unstructured":"Li J, Xu S-Q, Zhao Y-M, Yu S, Ge L-H, Bao-Hua X. Comparison of the biological characteristics of human mesenchymal stem cells derived from exfoliated deciduous teeth, bone marrow, gingival tissue, and umbilical cord. Mol Med Rep. 2018;18(6):4969\u201377.","journal-title":"Mol Med Rep"},{"issue":"1","key":"2011_CR2","first-page":"633","volume":"20","author":"Y-T Guan","year":"2019","unstructured":"Guan Y-T, Xie Y, Li D-S, Zhu Y-Y, Zhang X-L, Feng Y-L, Chen Y-P, Xu L-J, Liao P-F, Wang G. Comparison of biological characteristics of mesenchymal stem cells derived from the human umbilical cord and decidua parietalis. Mol Med Rep. 2019;20(1):633\u20139.","journal-title":"Mol Med Rep"},{"issue":"5","key":"2011_CR3","first-page":"1248","volume":"21","author":"Z-X Han","year":"2013","unstructured":"Han Z-X, Shi Q, Wang D-K, Dong L, Lyu M. Basic biological characteristics of mesenchymal stem cells derived from bone marrow and human umbilical cord. J Exp Hematol. 2013;21(5):1248\u201355.","journal-title":"J Exp Hematol"},{"issue":"1","key":"2011_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00441-017-2699-4","volume":"372","author":"D Bharti","year":"2018","unstructured":"Bharti D, Shivakumar SB, Park J-K, Ullah I, Subbarao RB, Park J-S, Lee S-L, Park B-W, Rho G-J. Comparative analysis of human Wharton\u2019s jelly mesenchymal stem cells derived from different parts of the same umbilical cord. Cell Tissue Res. 2018;372(1):51\u201365.","journal-title":"Cell Tissue Res"},{"issue":"11","key":"2011_CR5","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1111\/jog.13432","volume":"43","author":"A Filip","year":"2017","unstructured":"Filip A, Dabrowski AB, Kulesza A, Sladowska A, Zolocinska A, Gala K, Paczek L, Wielgos M. Comparison of the paracrine activity of mesenchymal stem cells derived from human umbilical cord, amniotic membrane and adipose tissue. J Obstet Gynaecol Res. 2017;43(11):1758\u201368.","journal-title":"J Obstet Gynaecol Res"},{"key":"2011_CR6","first-page":"Article ID 1376","volume":"2015","author":"Z Cheng","year":"2015","unstructured":"Cheng Z, Lu Z, Kong W, Liang J, Xu X, Wu H, Feng X, Hua B, Wang H, Sun L. Umbilical cord-derived mesenchymal stem cells inhibit cadherin-11 expression by fibroblast-like synoviocytes in rheumatoid arthritis. J Immunol Res. 2015;2015:Article ID 137695 10 pages.","journal-title":"J Immunol Res"},{"issue":"23","key":"2011_CR7","first-page":"4905","volume":"20","author":"Z-M Bi","year":"2016","unstructured":"Bi Z-M, Zhou Q-F, Geng Y, Zhang H-M. Human umbilical cord mesenchymal stem cells ameliorate experimental cirrhosis through activation of keratinocyte growth factor by suppressing microRNA-199. Eur Rev Med Pharmacol Sci. 2016;20(23):4905\u201312.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"2011_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s13287-017-0668-1","volume":"8","author":"X Sun","year":"2017","unstructured":"Sun X, Hao H, Han Q, Song X, Liu J, Liang D, Han W, Yiming M. Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats. Stem Cell Res Ther. 2017;8(1):241\u201355.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"2011_CR9","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1096\/fj.201800131RR","volume":"33","author":"J Yao","year":"2019","unstructured":"Yao J, Zheng J, Cai J, Zeng K, Zhou C, JiebinZhang SL, Li H, Liang C, He L, Chen H, Hongyuan F, Zhang Q, Chen G, Yang Y, Zhang Y. Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate rat hepatic ischemia-reperfusion injury by suppressing oxidative stress and neutrophil inflammatory response. FASEB J. 2019;33(2):1695\u2013710.","journal-title":"FASEB J"},{"issue":"2","key":"2011_CR10","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1096\/fj.201800131RR","volume":"33","author":"J Yao","year":"2019","unstructured":"Yao J, Zheng J, Cai J, Zeng K, Zhou C, JiebinZhang SL, Li H, Liang C, He L, Chen H, Hongyuan F, Zhang Q, Chen G, Yang Y, Zhang Y. Extracellular vesicles derived from human umbilical cord mesenchymal stem cells alleviate rat hepatic ischemia-reperfusion injury by suppressing oxidative stress and neutrophil inflammatory response. FASEB J. 2019;33(2):1695\u2013710.","journal-title":"FASEB J"},{"key":"2011_CR11","first-page":"Article ID 9739","volume":"2019","author":"Z Bao","year":"2019","unstructured":"Bao Z, Zhang L, Liang C, Liu B, Pan X, Wang Y, Zhang Y, Yu Z, Xie W, Yan B, Liu F, Yip H-K, Yu X-Y, Li Y. Stem cell-derived exosomes prevent aging-induced cardiac dysfunction through a novel exosome\/lncRNA MALAT1\/NF-\u03ba B\/TNF-\u03b1 signaling pathway. Oxidative Med Cell Longev. 2019;2019:Article ID 9739258 14 pages.","journal-title":"Oxidative Med Cell Longev"},{"issue":"9","key":"2011_CR12","doi-asserted-by":"publisher","first-page":"16412","DOI":"10.1002\/jcp.28310","volume":"234","author":"Z-B Ruan","year":"2019","unstructured":"Ruan Z-B, Chen G-C, Zhang R, Zhu L. Circular RNA expression profiles during the differentiation of human umbilical cord\u2013derived mesenchymal stem cells into cardiomyocyte-like cells. J Cell Physiol. 2019;234(9):16412\u201323.","journal-title":"J Cell Physiol"},{"key":"2011_CR13","doi-asserted-by":"publisher","first-page":"e220","DOI":"10.1038\/emm.2016.7","volume":"48","author":"SH Kwak","year":"2016","unstructured":"Kwak SH, Park KS. Recent progress in genetic and epigenetic research on type 2 diabetes. Exp Mol Med. 2016;48:e220.","journal-title":"Exp Mol Med"},{"key":"2011_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.intimp.2018.04.051","volume":"60","author":"Y Yin","year":"2018","unstructured":"Yin Y, Hao H, Yu C, Gao J, Liu J, Xie Z, Zhang Q, Zang L, Han W, Yiming M. The homing of human umbilical cord-derived mesenchymal stem cells and the subsequent modulation of macrophage polarization in type 2 diabetic mice. Int Immunopharmacol. 2018;60:235\u201345.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"2011_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.2337\/dc15-0171","volume":"39","author":"J Cai","year":"2016","unstructured":"Cai J, Wu Z, Xu X, Liao L, Chen J, Huang L, Wu W, Luo F, Wu C, Pugliese A, Pileggi A, Ricordi C, Tan J. Umbilical cord mesenchymal stromal cell with autologous bone marrow cell transplantation in established type 1 diabetes: a pilot randomized controlled open-label clinical study to assess safety and impact on insulin secretion. Diabetes Care. 2016;39(1):149\u201357.","journal-title":"Diabetes Care"},{"issue":"12","key":"2011_CR16","first-page":"1969","volume":"60","author":"D Kong","year":"2014","unstructured":"Kong D, Zhuang X, Wang D, et al. Umbilical cord mesenchymal stem cell transfusion ameliorated hyperglycemia in patients with type 2 diabetes mellitus. Clin Lab. 2014;60(12):1969\u201376.","journal-title":"Clin Lab"},{"issue":"1","key":"2011_CR17","first-page":"29","volume":"45","author":"Y Wang","year":"2014","unstructured":"Wang Y, Dan Q-Q, Wang Q-P, Zhou N, Jin X-F, Hou Z-L, Peng B-K, Wang T-H. Human umbilic mesenchymal stromal cells repairs diabetic foot in rats associated with VEGF expressional change. J Sichuan Univ. 2014;45(1):29\u201333.","journal-title":"J Sichuan Univ"},{"issue":"6","key":"2011_CR18","first-page":"931","volume":"44","author":"N Zhou","year":"2013","unstructured":"Zhou N, Wang Q-P, Jin X-F, Hou Z-L, Peng B-K, Dan Q-Q, Wang T-H. Effect of human umbilici mesenchymal stromal cells implantation on the BDNF expression in diabetic foot rats. J Sichuan Univ. 2013;44(6):931\u20134.","journal-title":"J Sichuan Univ"},{"issue":"1\/2","key":"2011_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.7150\/ijbs.7237","volume":"10","author":"Q-S Zhao","year":"2014","unstructured":"Zhao Q-S, Xia N, Zhao N, Li M, Bi C-L, Zhu Q, Qiao G-F, Cheng Z-F. Localization of human mesenchymal stem cells from umbilical cord blood and their role in repair of diabetic foot ulcers in rats. Int J Biol Sci. 2014;10(1\/2):80\u20139.","journal-title":"Int J Biol Sci"},{"issue":"08","key":"2011_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1055\/s-0042-103684","volume":"124","author":"DM Treiman","year":"2016","unstructured":"Treiman DM. Clinical evaluation of human umbilical cord mesenchymal stem cell transplantation after angioplasty for diabetic foot. Exp Clin Endocrinol Diabetes. 2016;124(08):497\u2013503.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"2011_CR21","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1186\/s13287-020-01852-y","volume":"11","author":"E Xiang","year":"2020","unstructured":"Xiang E, Han B, Zhang Q, Rao W, Wang Z, Chang C, Zhang Y, Tu C, Li C, Wu D. Human umbilical cord-derivedmesenchymal stem cells prevent the progression of early diabetic nephropathythrough inhibiting inflammation and fibrosis. Stem Cell Res Ther. 2020;11(1):336\u201350.","journal-title":"Stem Cell Res Ther"},{"key":"2011_CR22","doi-asserted-by":"publisher","first-page":"107755","DOI":"10.1016\/j.diabres.2019.05.034","volume":"156","author":"Y Xian","year":"2019","unstructured":"Xian Y, Lin Y, Cao C, Li L, Wang J, Niu J, YunleiGuo YS, Wang Y, Wang W. Protective effect of umbilical cord mesenchymal stem cells combined with resveratrol against renal podocyte damage in NOD mice. Diabetes Res Clin Pract. 2019;156:107755\u201364.","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"2011_CR23","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1111\/jocd.12931","volume":"18","author":"S-S Hashemi","year":"2019","unstructured":"Hashemi S-S, Mohammadi AA, Kabiri H, Hashempoor MR, Mahmoodi M, Amini M, Mehrabani D. The healing effect of Wharton\u2019s jelly stem cells seeded on biological scaffold in chronic skin ulcers: a randomized clinical trial. J Cosmet Dermatol. 2019;18(6):1961\u20137.","journal-title":"J Cosmet Dermatol"},{"issue":"1","key":"2011_CR24","first-page":"39","volume":"11","author":"S Zhang","year":"2020","unstructured":"Zhang S, Chen L, Zhang G, Zhang B. Umbilical cord-matrix stem cells induce the functional restoration of vascular endothelial cells and enhance skin wound healing in diabetic mice via the polarized macrophages. BioMed Central. 2020;11(1):39\u201354.","journal-title":"BioMed Central"},{"key":"2011_CR25","first-page":"Article ID 7430","volume":"2020","author":"C Yue","year":"2020","unstructured":"Yue C, Guo Z, Luo Y, Yuan J, Wan X, Mo Z. c-Jun overexpression accelerates wound healing in diabetic rats by human umbilical cord-derived mesenchymal stem cells. Stem Cells Int. 2020;2020:Article ID 7430968 10 pages.","journal-title":"Stem Cells Int"},{"issue":"1","key":"2011_CR26","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/s41598-017-00298-2","volume":"7","author":"Z Wei","year":"2017","unstructured":"Wei Z, Wang Y, Kong J, Dong M, Hongtao D, Song C. Therapeutic efficacy of neural stem cells originating from umbilical cord-derived mesenchymal stem cells in diabetic retinopathy. Sci Rep. 2017;7(1):408\u201316.","journal-title":"Sci Rep"},{"issue":"5","key":"2011_CR27","doi-asserted-by":"publisher","first-page":"591","DOI":"10.7150\/ijms.38078","volume":"17","author":"C Yu","year":"2020","unstructured":"Yu C, Yang K, Meng X, Cao B, Wang F. Downregulation of long noncoding RNA MIAT in the retina of diabetic rats with tail-vein injection of human umbilical-cord mesenchymal stem cells. Int J Med Sci. 2020;17(5):591\u20138.","journal-title":"Int J Med Sci"},{"issue":"5","key":"2011_CR28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3390\/cells8050503","volume":"8","author":"O Krenkel","year":"2019","unstructured":"Krenkel O, Hundertmark J, Ritz TP, Weiskirchen R, Tacke F. Single cell RNA sequencing identifies subsets of hepatic stellate cells and myofibroblasts in liver fibrosis. Cells. 2019;8(5):503.","journal-title":"Cells."},{"issue":"5","key":"2011_CR29","first-page":"2545","volume":"41","author":"L-T Zhang","year":"2018","unstructured":"Zhang L-T, Peng X-B, Fang X-Q, Li J-F, Chen H, Mao X-R. Human umbilical cord mesenchymal stem cells inhibit proliferation of hepatic stellate cells in vitro. Int J Mol Med. 2018;41(5):2545\u201352.","journal-title":"Int J Mol Med"},{"issue":"46","key":"2011_CR30","doi-asserted-by":"publisher","first-page":"8152","DOI":"10.3748\/wjg.v23.i46.8152","volume":"23","author":"G-Z Zhang","year":"2017","unstructured":"Zhang G-Z, Sun H-C, Zheng L-B, Guo J-B, Zhang X-L. In vivo hepatic differentiation potential of human umbilical cord-derived mesenchymal stem cells: therapeutic effect on liver fibrosis\/cirrhosis. World J Gastroenterol. 2017;23(46):8152\u201368.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"2011_CR31","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1053\/j.gastro.2016.12.003","volume":"152","author":"SY An","year":"2017","unstructured":"An SY, Jang YJ, Lim H-J, Han J, Lee J, Lee G, Park JY, Park S-Y, Kim JH, Do B-R, Han C, Park H-K, Kim O-H, Song MJ, Kim S-J, Kim J-H. Milk fat globule-EGF factor 8, secreted by mesenchymal stem cells, protects against liver fibrosis in mice. Gastroenterology. 2017;152(5):1174\u201386.","journal-title":"Gastroenterology."},{"issue":"3","key":"2011_CR32","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.bbrc.2018.11.189","volume":"508","author":"L Jiang","year":"2019","unstructured":"Jiang L, Zhang S, Hu H, Yang J, Wang X, Ma Y, Jiang J, Wang J, Lin Z, Chen M, Wang H, Yu H, Zhu RR, Zhang Q. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate acute liver failure by reducing the activity of the NLRP3 inflammasome in macrophages. Biochem Biophys Res Commun. 2019;508(3):735\u201341.","journal-title":"Biochem Biophys Res Commun"},{"key":"2011_CR33","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.yrtph.2016.09.029","volume":"81","author":"J-W Yun","year":"2016","unstructured":"Yun J-W, Ahn JH, Kwon E, Kim S-H, Kim H, Jang J-J, Kim WH, Kim JH, Han S-y, Kim JT, Kim J-H, Kim W, Seung-Yup K, Do B-R, Kang B-C. Human umbilical cord-derived mesenchymal stem cells in acute liver injury: hepatoprotective efficacy, subchronic toxicity, tumorigenicity, and biodistribution. Regul Toxicol Pharmacol. 2016;81:437\u201347.","journal-title":"Regul Toxicol Pharmacol"},{"issue":"3","key":"2011_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10238-016-0427-0","volume":"17","author":"W Dandan","year":"2017","unstructured":"Dandan W, Lingying N, Xuebing F, Xinran Y, Shengnan Z, Huayong Z, Jun L, Cheng Z, Hong W, Bingzhu H, Lingyun S. Long-term safety of umbilical cord mesenchymal stem cells transplantation for systemic lupus erythematosus: a 6-year follow-up study. Clin Exp Med. 2017;17(3):333\u201340.","journal-title":"Clin Exp Med"},{"issue":"11","key":"2011_CR35","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s10067-014-2754-4","volume":"33","author":"F Gu","year":"2014","unstructured":"Gu F, Wang D, Zhang H, Feng X, Gilkeson GS, Shi S, Sun L. Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy. Clin Rheumatol. 2014;33(11):1611\u20139.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"2011_CR36","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.stemcr.2018.01.029","volume":"10","author":"D Wang","year":"2018","unstructured":"Wang D, Zhang H, Liang J, Wang H, Hua B, Feng X, Gilkeson GS, Farge D, Shi S, Sun L. A long-term follow-up study of allogeneic mesenchymal stem\/ stromal cell transplantation in patients with drug-resistant systemic lupus erythematosus. Stem Cell Rep. 2018;10(3):933\u201341.","journal-title":"Stem Cell Rep"},{"issue":"5","key":"2011_CR37","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/cmi.2015.89","volume":"14","author":"D Wang","year":"2017","unstructured":"Wang D, Huang S, Yuan X, Liang J, Xu R, Yao G, Feng X, Sun L. The regulation of the Treg\/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus. Cell Mol Immunol. 2017;14(5):423\u201331.","journal-title":"Cell Mol Immunol"},{"issue":"5","key":"2011_CR38","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1021\/acs.molpharmaceut.7b01146","volume":"15","author":"S Mai","year":"2018","unstructured":"Mai S, Lin Z, Tian X, Liao X, Luan Y, XingHan YW, Wu Y, Kuang S, Yang Y, Ma J, Chen Q, Yang J. Double-edged effect of hydroxychloroquine on human umbilical cord-derived mesenchymal stem cells treating lupus nephritis in MRL\/lpr mice. Mol Pharm. 2018;15(5):1800\u201313.","journal-title":"Mol Pharm"},{"issue":"4","key":"2011_CR39","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/08916934.2020.1750011","volume":"53","author":"D Li","year":"2020","unstructured":"Li D, Li X, Duan M, Dou Y, Feng Y, Nan N, Zhang W. MiR-153-3p induces immune dysregulation by inhibiting PELI1 expression in umbilical cord-derived mesenchymal stem cells in patients with systemic lupus erythematosus. Autoimmunity. 2020;53(4):201\u20139.","journal-title":"Autoimmunity."},{"issue":"2","key":"2011_CR40","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1177\/0961203319896417","volume":"29","author":"B Zheng","year":"2020","unstructured":"Zheng B, Zhang P, Yuan L, Chhetri RK, Guo Y, Deng D. Effects of human umbilical cord mesenchymal stem cells on inflammatory factors and miR-181a in T lymphocytes from patients with systemic lupus erythematosus. Lupus. 2020;29(2):126\u201335.","journal-title":"Lupus."},{"key":"2011_CR41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/5584_2019_343","volume":"1084","author":"TT-T Dao","year":"2019","unstructured":"Dao TT-T, Nguyen CT-H, Ngoc Bich V, Le HT-N, Nguyen PD-N, Van Pham P. Evaluation of proliferation and osteogenic differentiation of human umbilical cord-derived mesenchymal stem cells in porous scaffolds. Adv Exp Med Biol. 2019;1084:207\u201320.","journal-title":"Adv Exp Med Biol"},{"key":"2011_CR42","first-page":"Article ID 1983","volume":"2018","author":"B-Y Zhang","year":"2018","unstructured":"Zhang B-Y, Wang B-Y, Li S-C, Luo D-Z, Zhan X, Chen S-F, Chen Z-S, Liu C-Y, Ji H-Q, Bai Y-S, Li D-S, Yang H. Evaluation of the curative effect of umbilical cord mesenchymal stem cell therapy for knee arthritis in dogs using imaging technology. Stem Cells Int. 2018;2018:Article ID 1983025 12 pages.","journal-title":"Stem Cells Int"},{"issue":"2","key":"2011_CR43","first-page":"288","volume":"35","author":"Y Sun","year":"2017","unstructured":"Sun Y, Kong W, Huang S, Shi B, Zhang H, Chen W, Zhang H, Cheng Z, Tang X, Yao G, Feng X, Sun L. Comparable therapeutic potential of umbilical cord mesenchymal stem cells in collagen-induced arthritis to TNF inhibitor or anti-CD20 treatment. Clin Exp Rheumatol. 2017;35(2):288\u201395.","journal-title":"Clin Exp Rheumatol"},{"key":"2011_CR44","doi-asserted-by":"publisher","first-page":"105687","DOI":"10.1016\/j.intimp.2019.105687","volume":"74","author":"D Ma","year":"2019","unstructured":"Ma D, Xu K, Zhang G, Yang L, Gao J, Tian M, Wei C, Li J, Zhang L. Immunomodulatory effect of human umbilical cord mesenchymal stem cells on T lymphocytes in rheumatoid arthritis. Int Immunopharmacol. 2019;74:105687.","journal-title":"Int Immunopharmacol"},{"key":"2011_CR45","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.2147\/DDDT.S225613","volume":"13","author":"L Wang","year":"2019","unstructured":"Wang L, Huang S, Li S, Li M, Shi J, Bai W, Wang Q, Zheng L, Liu Y. Efficacy and safety of umbilical cord mesenchymal stem cell therapy for rheumatoid arthritis patients: a prospective phase I\/II study. Drug Des Devel Ther. 2019;13:4331\u201340.","journal-title":"Drug Des Devel Ther"},{"issue":"12","key":"2011_CR46","first-page":"1472","volume":"30","author":"Y Wang","year":"2016","unstructured":"Wang Y, Jin W, Liu H, Cui Y, Mao Q, Fei Z, Xiang C. Curative effect of human umbilical cord mesenchymal stem cells by intra-articular injection for degenerative knee osteoarthritis. Chinese J Reparative Reconstr Surg. 2016;30(12):1472\u20137.","journal-title":"Chinese J Reparative Reconstr Surg"},{"issue":"3","key":"2011_CR47","first-page":"4474","volume":"17","author":"H Wang","year":"2018","unstructured":"Wang H, Xu Y, Jiang Y, Zheng W, Li Y, Shao Q. The human umbilical cord stem cells improve the viability of OA degenerated chondrocytes. Mol Med Rep. 2018;17(3):4474\u201382.","journal-title":"Mol Med Rep"},{"key":"2011_CR48","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/5584_2017_9","volume":"1020","author":"B Sadlik","year":"2017","unstructured":"Sadlik B, Jaroslawski G, Gladysz D, Puszkarz M, Markowska M, Pawelec K, Boruczkowski D, Oldak T. Knee cartilage regeneration with umbilical cord mesenchymal stem cells embedded in collagen scaffold using dry arthroscopy technique. Adv Exp Med Biol. 2017;1020:113\u201322.","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"2011_CR49","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/sctm.18-0053","volume":"8","author":"J Matas","year":"2019","unstructured":"Matas J, Orrego M, Amenabar D, Infante C, Tapia-Limonchi R, Cadiz MI, Alcayaga-Miranda F, Gonz\u00e1lez PL, Muse E, Khoury M, Figueroa FE, Espinoza F. Umbilical cord-derived mesenchymal stromal cells (MSCs) for knee osteoarthritis: repeated MSC dosing is superior to a single MSC dose and to hyaluronic acid in a controlled randomized phase I\/II trial. Stem Cells Transl Med. 2019;8(3):215\u201324.","journal-title":"Stem Cells Transl Med"},{"key":"2011_CR50","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.brainres.2013.08.001","volume":"1532","author":"S Wang","year":"2013","unstructured":"Wang S, Cheng H, Dai G, Wang X, RongrongHua XL, Wang P, Chen G, Wu Y, An Y. Umbilical cord mesenchymal stem cell transplantation significantly improves neurological function in patients with sequelae of traumatic brain injury. Brain Res. 2013;1532:76\u201384.","journal-title":"Brain Res"},{"issue":"6","key":"2011_CR51","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1097\/SCS.0000000000003563","volume":"28","author":"H-J Dong","year":"2017","unstructured":"Dong H-J, Shang C-Z, Li G, Niu Q, Luo Y-C, Yang Y, Meng H-P, Yin H-J, Zhang H-X, Zhao M-L, Lin L. The distribution of transplanted umbilical cord mesenchymal stem cells in large blood vessel of experimental design with traumatic brain injury. J Craniofac Surg. 2017;28(6):1615\u20139.","journal-title":"J Craniofac Surg"},{"issue":"7","key":"2011_CR52","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1097\/SCS.0000000000005042","volume":"29","author":"L Qi","year":"2018","unstructured":"Qi L, Xue X, Sun J, Wu Q, Wang H, Guo Y, Sun B. The promising effects of transplanted umbilical cord mesenchymal stem cells on the treatment in traumatic brain injury. J Craniofac Surg. 2018;29(7):1689\u201392.","journal-title":"J Craniofac Surg"},{"issue":"11","key":"2011_CR53","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1177\/0963689717728936","volume":"26","author":"W Lin","year":"2017","unstructured":"Lin W, Hsuan YC-Y, Lin M-T, et al. Human umbilical cord mesenchymal stem cells preserve adult newborn neurons and reduce neurological injury after cerebral ischemia by reducing the number of hypertrophic microglia\/macrophages. Cell Transplant. 2017;26(11):1798\u2013810.","journal-title":"Cell Transplant"},{"issue":"8","key":"2011_CR54","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3390\/cells8080855","volume":"8","author":"G Thomi","year":"2019","unstructured":"Thomi G, Joerger-Messerli M, Haesler V, Muri L, Surbek D, Schoeberlein A. Intranasally administered exosomes from umbilical cord stem cells have preventive neuroprotective effects and contribute to functional recovery after perinatal brain injury. Cells. 2019;8(8):855.","journal-title":"Cells."},{"issue":"16","key":"2011_CR55","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1089\/scd.2016.0027","volume":"25","author":"B Oppliger","year":"2016","unstructured":"Oppliger B, Joerger-Messerli M, Mueller M, Reinhart U, Schneider P, Surbek DV, Schoeberlein A. Intranasal delivery of umbilical cord-derived mesenchymal stem cells preserves myelination in perinatal brain damage. Stem Cells Dev. 2016;25(16):1234\u201342.","journal-title":"Stem Cells Dev"},{"issue":"1","key":"2011_CR56","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/j.pain.0000000000001395","volume":"60","author":"S-J Shiue","year":"2019","unstructured":"Shiue S-J, Rau R-H, Shiue H-S, Hung Y-W, Li Z-X, Yang KD, Cheng J-K. Mesenchymal stem cell exosomes as a cell-free therapy for nerve injury-induced pain in rats. Pain. 2019;60(1):210\u201323.","journal-title":"Pain."},{"issue":"12","key":"2011_CR57","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.3727\/096368912X658818","volume":"22","author":"Y Jiang","year":"2013","unstructured":"Jiang Y, Zhu W, Zhu J, et al. Feasibility of delivering mesenchymal stem cells via catheter to the proximal end of the lesion artery in patients with stroke in the territory of the middle cerebral artery. Cell Transplant. 2013;22(12):2291\u20138.","journal-title":"Cell Transplant"},{"key":"2011_CR58","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3389\/fneur.2018.00133","volume":"9","author":"E Tanaka","year":"2018","unstructured":"Tanaka E, Ogawa Y, Mukai T, Sato Y, Hamazaki T, Nagamura-Inoue T, Harada-Shiba M, Shintaku H, Tsuji M. Dose-dependent effect of intravenous administration of human umbilical cord-derived mesenchymal stem cells in neonatal stroke mice. Front Neurol. 2018;9:133\u201345.","journal-title":"Front Neurol"},{"issue":"11","key":"2011_CR59","first-page":"2176","volume":"7","author":"Q Zhang","year":"2015","unstructured":"Zhang Q, Shang X, Hao M, Zheng M, Li Y, Liang Z, Cui Y, Liu Z. Effects of human umbilical cord mesenchymal stem cell transplantation combined with minimally invasive hematoma aspiration on intracerebral hemorrhage in rats. Am J Transl Res. 2015;7(11):2176\u201386.","journal-title":"Am J Transl Res"},{"issue":"1","key":"2011_CR60","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jcyt.2015.10.006","volume":"18","author":"G-H Wang","year":"2016","unstructured":"Wang G-H, Yang L, Wu X-B, Lu Y, Liu J, Qin Y-R, Li T, Duan H-F. Neuroprotective effects of human umbilical cord\u2013derived mesenchymal stromal cells combined with nimodipine against radiation-induced brain injury through inhibition of apoptosis. Cytotherapy. 2016;18(1):53\u201364.","journal-title":"Cytotherapy."},{"issue":"1","key":"2011_CR61","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s13287-018-0888-z","volume":"9","author":"L Meikuang","year":"2018","unstructured":"Meikuang L, Wang W, Lu L, Zhi-Bo H, Zongjin L, Jie G, Meng Z, Honghong J, Jie F, Zhe W, Baoquan S, Jiemin Z, Jun L, Tianwen L, Wang F, Ting L, Jianming L, Yihu F, Gao J, Zhongchao H. Intravenous injection of allogeneic umbilical cord-derived multipotent mesenchymal stromal cells reduces the infarct area and ameliorates cardiac function in a porcine model of acute myocardial infarction. Stem Cell Res Ther. 2018;9(1):129.","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"2011_CR62","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1161\/CIRCRESAHA.117.310712","volume":"121","author":"J Bartolucci","year":"2017","unstructured":"Bartolucci J, Verdugo FJ, Gonz\u00e1lez PL, Larrea RE, Abarzua E, Goset C, Rojo P, Palma I, Lamich R, Pedreros PA, Valdivia G, Lopez VM, Nazzal C, Alcayaga-Miranda F, Cuenca J, Brobeck MJ, Patel AN, Figueroa FE, Khoury M. Safety and efficacy of the intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure: a phase 1\/2 randomized controlled trial (RIMECARD trial [randomized clinical trial of intravenous infusion umbilical cord mesenchymal stem cells on cardiopathy]). Circ Res. 2017;121(10):1192\u2013204.","journal-title":"Circ Res"},{"issue":"5","key":"2011_CR63","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.3892\/etm.2016.3748","volume":"12","author":"Z Fang","year":"2016","unstructured":"Fang Z, Yin X, Wang J, Tian N, Ao Q, Yongquan G, Liu Y. Functional characterization of human umbilical cord-derived mesenchymal stem cells for treatment of systolic heart failure. Exp Ther Med. 2016;12(5):3328\u201332.","journal-title":"Exp Ther Med"},{"key":"2011_CR64","first-page":"Article ID 1958","volume":"2019","author":"J Ni","year":"2019","unstructured":"Ni J, Liu X, Yin Y, Zhang P, Xu Y-W, Zheng L. Exosomes derived from TIMP2-modified human umbilical cord mesenchymal stem cells enhance the repair effect in rat model with myocardial infarction possibly by the Akt\/Sfrp2 pathway. Oxidative Med Cell Longev. 2019;2019:Article ID 1958941 19 pages.","journal-title":"Oxidative Med Cell Longev"},{"key":"2011_CR65","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.biopha.2016.01.020","volume":"78","author":"Z Ruan","year":"2016","unstructured":"Ruan Z, Zhu L, Yin Y, Chen G. Overexpressing NKx2.5 increases the differentiation of human umbilical cord derived mesenchymal stem cells into cardiomyocyte-like cells. Biomed Pharmacother. 2016;78:110\u20135.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"2011_CR66","doi-asserted-by":"publisher","first-page":"318","DOI":"10.2174\/1566524019666191017150416","volume":"20","author":"L Yang","year":"2020","unstructured":"Yang L, Zhu S, Li Y, Zhuang J, Chen J, HuanleiHuang YC, Wen Y, Wen Y, Guo H, Fan X, WuzhouYuan ZJ, Wang Y, Wu X, Zhu P. Overexpression of Pygo2 increases differentiation of human umbilical cord derived mesenchymal stem cells into cardiomyocyte-like cells. Curr Mol Med. 2020;20(4):318\u201324.","journal-title":"Curr Mol Med"},{"issue":"4","key":"2011_CR67","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s10616-015-9886-5","volume":"68","author":"Z-B Ruan","year":"2016","unstructured":"Ruan Z-B, Zhu L, Yin Y-G, Chen G-C. Inhibitor of p53-p21 pathway induces the differentiation of human umbilical cord derived mesenchymal stem cells into cardiomyogenic cells. Cytotechnology. 2016;68(4):1257\u201365.","journal-title":"Cytotechnology."},{"issue":"1","key":"2011_CR68","first-page":"71","volume":"17","author":"C Zhang","year":"2018","unstructured":"Zhang C, Zhou G, Chen Y, Liu S, Chen F, Xie L, Wang W, Zhang Y, Wang T, Lai X, Ma L. Human umbilical cord mesenchymal stem cells alleviate interstitial fibrosis and cardiac dysfunction in a dilated cardiomyopathy rat model by inhibiting TNF-\u03b1 and TGF-\u03b21\/ERK1\/2 signaling pathways. Mol Med Rep. 2018;17(1):71\u20138.","journal-title":"Mol Med Rep"},{"issue":"6","key":"2011_CR69","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1177\/0963689718766279","volume":"27","author":"Z Xiao","year":"2018","unstructured":"Xiao Z, Tang F, Zhao Y, et al. Significant improvement of acute complete spinal cord injury patients diagnosed by a combined criteria implanted with neuro regen scaffolds and mesenchymal stem cells. Cell Transplant. 2018;27(6):907\u201315.","journal-title":"Cell Transplant"},{"issue":"09","key":"2011_CR70","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.4103\/1673-5374.276340","volume":"15","author":"W-S Deng","year":"2020","unstructured":"Deng W-S, Ma K, Liang B, Liu X-Y, Xu H-Y, Zhang J, Shi H-Y, Sun H-T, Chen X-Y, Zhang S. Collagen scaffold combined with human umbilical cord-mesenchymal stem cells transplantation for acute complete spinal cord injury. Neural Regen Res. 2020;15(09):1686\u2013700.","journal-title":"Neural Regen Res"},{"issue":"7","key":"2011_CR71","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1177\/0963689719844525","volume":"28","author":"L Sun","year":"2019","unstructured":"Sun L, Wang F, Chen H, et al. Co-transplantation of human umbilical cord mesenchymal stem cells and human neural stem cells improves the outcome in rats with spinal cord injury. Cell Transplant. 2019;28(7):893\u2013906.","journal-title":"Cell Transplant"},{"issue":"30","key":"2011_CR72","first-page":"2366","volume":"97","author":"CH Yang","year":"2017","unstructured":"Yang CH, Yu BQ, You QH, Feng JJ. Human umbilical cord mesenchymal stem cell transplantation for the treatment of two noncontinuous segments spinal cord compression injury in rabbits. Natl Med J China. 2017;97(30):2366\u201371.","journal-title":"Natl Med J China"},{"key":"2011_CR73","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.msec.2016.12.017","volume":"74","author":"G Jiao","year":"2017","unstructured":"Jiao G, Lou G, Mo Y, Pan Y, Zhang Z, Guo R, Li Z. A combination of GDNF and hUCMSC transplantation loaded on SF\/AGs composite scaffolds for spinal cord injury repair. Mater Sci Eng C. 2017;74:230\u20137.","journal-title":"Mater Sci Eng C"},{"issue":"3 Suppl","key":"2011_CR74","first-page":"47","volume":"23","author":"D-Z Tian","year":"2019","unstructured":"Tian D-Z, Deng D, Qiang J-L, Zhu Q, Li Q-C, Yi Z-G. Repair of spinal cord injury in rats by umbilical cord mesenchymal stem cells through P38MAPK signaling pathway. Eur Rev Med Pharmacol Sci. 2019;23(3 Suppl):47\u201353.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2011_CR75","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.msec.2018.04.006","volume":"89","author":"G Sun","year":"2018","unstructured":"Sun G, Li G, Li D, Huang W, Zhang R, Zhang H, Duan Y, Wang B. hucMSC derived exosomes promote functional recovery in spinal cord injury mice via attenuating inflammation. Mater Sci Eng C. 2018;89:194\u2013204.","journal-title":"Mater Sci Eng C"},{"key":"2011_CR76","first-page":"Article ID 7650","volume":"2020","author":"L-L Wu","year":"2020","unstructured":"Wu L-L, Xiao-Ming P, Hao-Hao C, Xiao-Yan F, Jinzhan J, Ming-Xing D. Repairing and analgesic effects of umbilical cord mesenchymal stem cell transplantation in mice with spinal cord injury. Biomed Res Int. 2020;2020:Article ID 7650354 10 pages.","journal-title":"Biomed Res Int"},{"issue":"11","key":"2011_CR77","first-page":"811","volume":"30","author":"W-w Liu","year":"2012","unstructured":"Liu W-w, Yu W, Chen J-y, Ye G-x, Liu Y-m, Chen L-z, Chen Y-x, Cheng Z, Zhong X-y. Effects of human umbilical cord mesenchymal stem cells in the treatment of paraquat-induced lung injury. Chinese J Ind Hyg Occup Dis. 2012;30(11):811\u20135.","journal-title":"Chinese J Ind Hyg Occup Dis"},{"issue":"4","key":"2011_CR78","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.ijrobp.2018.04.007","volume":"101","author":"D Liu","year":"2018","unstructured":"Liu D, Kong F, Yuan Y, Seth P, Xu W, Wang H, Xiao F, Wang L, Zhang Q, Yang Y, Wang H. Decorin-modified umbilical cord mesenchymal stem cells (MSCs) attenuate radiation-induced lung injuries via regulating inflammation, fibrotic factors, and immune responses. Int J Radiat Oncol Biol Phys. 2018;101(4):945\u201356.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2011_CR79","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3349\/ymj.2017.58.1.206","volume":"58","author":"ZW Huang","year":"2017","unstructured":"Huang ZW, Liu N, Dong L, Zhang HY, Wang Y, Liu Y, Zhang LL, Xiu LJ. Angiopoietin-1 modified human umbilical cord mesenchymal stem cell therapy for endotoxin-induced acute lung injury in rats. Yonsei Med J. 2017;58(1):206\u201316.","journal-title":"Yonsei Med J"},{"issue":"2","key":"2011_CR80","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ijrobp.2018.05.068","volume":"102","author":"Y Hao","year":"2018","unstructured":"Hao Y, Ran Y, Lu B, Li J, Zhang J, Feng C, Fang J, Ma R, Qiao Z, Dai X, Xiong W, Liu J, Zhou Q, Hao J, Li R, Dai J. Therapeutic effects of human umbilical cord\u2013derived mesenchymal stem cells on canine radiation-induced lung injury. Int J Radiat Oncol Biol Phys. 2018;102(2):407\u201316.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2011_CR81","doi-asserted-by":"publisher","first-page":"39889","DOI":"10.1038\/srep39889","volume":"7","author":"H Zhu","year":"2017","unstructured":"Zhu H, Xiong Y, Xia Y, Zhang R, Tian D, Wang T, Dai J, Wang L, Yao H, Jiang H, Yang K, Liu E, Shi Y, Zhou F, Gao L, Lin Z. Therapeutic effects of human umbilical cord-derived mesenchymal stem cells in acute lung injury mice. Sci Rep. 2017;7:39889\u2013900.","journal-title":"Sci Rep"},{"issue":"12","key":"2011_CR82","doi-asserted-by":"publisher","first-page":"5914","DOI":"10.4049\/jimmunol.1300667","volume":"191","author":"LJ Mathias","year":"2013","unstructured":"Mathias LJ, Khong SML, Spyroglou L, Payne NL, Siatskas C, Thorburn AN, Boyd RL, Heng TSP. Alveolar macrophages are critical for the inhibition of allergic asthma by mesenchymal stromal cells. J Immunol. 2013;191(12):5914\u201324.","journal-title":"J Immunol"},{"issue":"2","key":"2011_CR83","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41419-018-0323-5","volume":"9","author":"L Dong","year":"2018","unstructured":"Dong L, Yanan P, Zhang L, Qi Q, Xu L, Li W, Wei C, Wang X, Zhou S, Zhu J, Wang X, Liu F, Chen X, Su C. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles promote lung adenocarcinoma growth by transferring miR-410. Cell Death Dis. 2018;9(2):218.","journal-title":"Cell Death Dis"},{"issue":"12","key":"2011_CR84","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/JCMA.0000000000000189","volume":"82","author":"J-S Liu","year":"2019","unstructured":"Liu J-S, Juan D, Cheng X, Zhang X-Z, Li Y, Chen X-L. Exosomal miR-451 from human human umbilical cord mesenchymal stem cells attenuates burn-induced acute lung injury. J Chin Med Assoc. 2019;82(12):895\u2013901.","journal-title":"J Chin Med Assoc"},{"key":"2011_CR85","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.gene.2017.08.006","volume":"630","author":"L Yang","year":"2017","unstructured":"Yang L, Xu S, Yang L, Mou Y, Li Y, Dang R, Li C. Hypoxia promotes the skewed differentiation of umbilical cord mesenchymal stem cells toward type II alveolar epithelial cells by regulating microRNA-145. Gene. 2017;630:68\u201375.","journal-title":"Gene."},{"issue":"2","key":"2011_CR86","first-page":"E71","volume":"23","author":"S Atluri","year":"2020","unstructured":"Atluri S, Manchikanti L, Hirsch JA. Expanded umbilical cord mesenchymal stem cells (UC-MSCs) as a therapeutic strategy in managing critically ill COVID-19 patients: the case for compassionate use. Pain Physician. 2020;23(2):E71\u201383.","journal-title":"Pain Physician"},{"issue":"2","key":"2011_CR87","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1093\/infdis\/jiy478","volume":"219","author":"H Loy","year":"2019","unstructured":"Loy H, Kuok DIT, Hui KPY, Choi MHL, Yuen W, Nicholls JM, Peiris JSM, Chan MCW. Therapeutic implications of human umbilical cord mesenchymal stromal cells in attenuating influenza A(H5N1) virus-associated acute lung injury. J Infect Dis. 2019;219(2):186\u201396.","journal-title":"J Infect Dis"},{"issue":"8","key":"2011_CR88","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1097\/QAD.0b013e32835fab77","volume":"27","author":"Z Zheng","year":"2013","unstructured":"Zheng Z, Junliang F, Xu X, Wang S, Xu R, MinZhao WN, Wang X, Zhang J, Li T, Su L, Wang F-S. Safety and immunological responses to human mesenchymal stem cell therapy in difficult-to-treat HIV-1-infected patients. AIDS. 2013;27(8):1283\u201393.","journal-title":"AIDS."},{"issue":"1","key":"2011_CR89","doi-asserted-by":"publisher","first-page":"12484","DOI":"10.1038\/s41598-017-11997-1","volume":"7","author":"P Chen","year":"2017","unstructured":"Chen P, Zhang K-H, Na T, Lin W, Yin W-D, Yuan B-Z, Wang J-Z. The hUC-MSCs cell line CCRC-1 represents a novel, safe and high-yielding HDCs for the production of human viral vaccines. Sci Rep. 2017;7(1):12484.","journal-title":"Sci Rep"},{"issue":"24","key":"2011_CR90","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1200\/JCO.2015.65.3642","volume":"34","author":"L Gao","year":"2016","unstructured":"Gao L, Zhang Y, Hu B, Liu J, Kong P, Lou S, Yi S, Yang T, Li H, Liu Y, Cheng Z, Gao L, LidanZhu QW, Wang P, Chen X, Zhong J, Zhang X. Phase II multicenter, randomized, double-blind controlled study of efficacy and safety of umbilical cord-derived mesenchymal stromal cells in the prophylaxis of chronic graft-versus-host disease after HLA-haploidentical stem-cell transplantation. J Clin Oncol. 2016;34(24):2843\u201350.","journal-title":"J Clin Oncol"},{"key":"2011_CR91","doi-asserted-by":"crossref","unstructured":"Li Q, Chen C-F, Wang D-Y, L\u00fc Y-T, Huan Y, Fang S-X, Han Y, Ge R-C, Chen X-W. Changes in growth factor levels in the cerebrospinal fluid of autism patients after transplantation of human umbilical cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells. Genet Mol Res. 2016;15(2).","DOI":"10.4238\/gmr.15027526"},{"issue":"5","key":"2011_CR92","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.3892\/mmr.2016.5745","volume":"14","author":"C Chen","year":"2016","unstructured":"Chen C, Zhiguo Q, Yin X, Shang C, Ao Q, Yongquan G, Liu Y. Efficacy of umbilical cord-derived mesenchymal stem cell-based therapy for osteonecrosis of the femoral head: a three-year follow-up study. Mol Med Rep. 2016;14(5):4209\u201315.","journal-title":"Mol Med Rep"},{"issue":"12","key":"2011_CR93","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1007\/s11427-017-9272-2","volume":"61","author":"L Ding","year":"2018","unstructured":"Ding L, Yan G, Bin Wang LX, Yan G, Tong R, Cui X, LeiLei JL, Sheng X, Wang B, Zhang C, Yang Y, Jiang R, Zhou J, Kong N, Lu F, Zhou H, Zhao Y, Chen B, Hu Y, Dai J, Sun H. Transplantation of UC-MSCs on collagen scaffold activates follicles in dormant ovaries of POF patients with long history of infertility. Sci China Life Sci. 2018;61(12):1554\u201365.","journal-title":"Sci China Life Sci"},{"key":"2011_CR94","first-page":"Article ID 5356","volume":"2017","author":"F Mao","year":"2017","unstructured":"Mao F, Wu Y, Tang X, Kang J, Zhang B, Yan Y, Qian H, Zhang X, Xu W. Exosomes derived from human umbilical cord mesenchymal stem cells relieve inflammatory bowel disease in mice. Biomed Res Int. 2017;2017:Article ID 5356760 12 pages.","journal-title":"Biomed Res Int"},{"issue":"11","key":"2011_CR95","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1007\/s11064-018-2641-5","volume":"43","author":"D Mao","year":"2018","unstructured":"Mao D, Yang S, Wang P, Xie Z, Xu S, Zhu ZY, Wang Y, Lyu Y, Wang D, Xu L, Bi JZ, Yang H. Exosomes isolated from human umbilical cord mesenchymal stem cells alleviate neuroinflammation and reduce amyloid-beta deposition by modulating microglial activation in Alzheimer\u2019s disease. Neurochem Res. 2018;43(11):2165\u201377.","journal-title":"Neurochem Res"},{"issue":"1","key":"2011_CR96","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12967-018-1433-7","volume":"16","author":"H Riordan Neil","year":"2018","unstructured":"Riordan Neil H, Isabela M, Giselle F, Nicole A, Fearnot Neal E, Leckrone Michael E, Jones MD, Darla M, Dorita A, Patel Amit N, Santosh K, Jorge PR. Clinical feasibility of umbilical cord tissue-derived mesenchymal stem cells in the treatment of multiple sclerosis. J Transl Med. 2018;16(1):57.","journal-title":"J Transl Med"},{"key":"2011_CR97","unstructured":"Gan X. China\u2019s first universal requirements for stem cells have been released [N]. Chinese Sci News. 2017;11-23(1)."},{"key":"2011_CR98","doi-asserted-by":"publisher","first-page":"905621","DOI":"10.4061\/2011\/905621","volume":"2011","author":"K Cooper","year":"2011","unstructured":"Cooper K, Viswanathan C. Establishment of a mesenchymal stem cell bank. Stem Cells Int. 2011;2011:905621.","journal-title":"Stem Cells Int"},{"issue":"6","key":"2011_CR99","doi-asserted-by":"publisher","first-page":"e98565","DOI":"10.1371\/journal.pone.0098565","volume":"9","author":"G Chen","year":"2014","unstructured":"Chen G, Yue A, Ruan Z, Yin Y, Wang RZ, Ren Y, Zhu L. Human umbilical cord-derived mesenchymal stem cells do not undergo malignant transformation during long-term culturing in serum-free medium. PLoS One. 2014;9(6):e98565.","journal-title":"PLoS One"},{"issue":"2","key":"2011_CR100","first-page":"370","volume":"40","author":"Y Wang","year":"2012","unstructured":"Wang Y, Fan H, Zhou B, Zhenyu J, Yu L, Guo L, Han J, Shixin L. Fusion of human umbilical cord mesenchymal stem cells with esophageal carcinoma cells inhibits the tumorigenicity of esophageal carcinoma cells. Int J Oncol. 2012;40(2):370\u20137.","journal-title":"Int J Oncol"},{"issue":"1","key":"2011_CR101","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12964-018-0279-1","volume":"16","author":"C Melzer","year":"2018","unstructured":"Melzer C, von der Ohe J, Hass R. MSC stimulate ovarian tumor growth during intercellular communication but reduce tumorigenicity after fusion with ovarian cancer cells. Cell Commun Signal. 2018;16(1):67.","journal-title":"Cell Commun Signal"},{"key":"2011_CR102","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1186\/s12885-015-1780-1","volume":"15","author":"J Xue","year":"2015","unstructured":"Xue J, Zhu Y, Sun Z, et al. Tumorigenic hybrids between mesenchymal stem cells and gastric cancer cells enhanced cancer proliferation, migration and stemness. BMC Cancer. 2015;15:793.","journal-title":"BMC Cancer"},{"issue":"5","key":"2011_CR103","first-page":"6982","volume":"15","author":"Q Li","year":"2018","unstructured":"Li Q, Pang Y, Liu T, Tang Y, Xie J, Zhang B, Hu C. Effects of human umbilical cord-derived mesenchymal stem cells on hematologic malignancies. Oncol Lett. 2018;15(5):6982\u201390.","journal-title":"Oncol Lett"},{"key":"2011_CR104","doi-asserted-by":"publisher","first-page":"9291013","DOI":"10.1155\/2016\/9291013","volume":"2016","author":"J Lian","year":"2016","unstructured":"Lian J, Lv S, Liu C, Yang L, Wang S, Guo X, Nan F, Yu H, He X, Sun G, Ma X. Effects of serial passage on the characteristics and cardiac and neural differentiation of human umbilical cord Wharton\u2019s jelly-derived mesenchymal stem cells. Stem Cells Int. 2016;2016:9291013.","journal-title":"Stem Cells Int"},{"issue":"1\u20132","key":"2011_CR105","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s11010-014-2303-0","volume":"401","author":"Z Shi","year":"2015","unstructured":"Shi Z, Liang Z, Qiu G, He R, Detamore MS. The effect of extended passaging on the phenotype and osteogenic potential of human umbilical cord mesenchymal stem cells. Mol Cell Biochem. 2015;401(1\u20132):155\u201364.","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"2011_CR106","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.3892\/mmr.2016.5537","volume":"14","author":"Y-M Tang","year":"2016","unstructured":"Tang Y-M, Bao W-M, Yang J-H, Ma L-K, Yang J, Xu Y, Yang L-H, Sha F, Xu Z-Y, Wu H-M, Zhou W, Li Y, Li Y-H. Umbilical cord-derived mesenchymal stem cells inhibit growth and promote apoptosis of HepG2 cells. Mol Med Rep. 2016;14(3):2717\u201324.","journal-title":"Mol Med Rep"},{"key":"2011_CR107","first-page":"7159465","volume":"2018","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Li Y, Li W, Cai J, Yue M, Jiang L, Xu R, Zhang L, Li J, Zhu C. Therapeutic effect of human umbilical cord mesenchymal stem cells at various passages on acute liver failure in rats. Stem Cells Int. 2018;2018:7159465.","journal-title":"Stem Cells Int"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-02011-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13287-020-02011-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-02011-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T07:41:11Z","timestamp":1606808471000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-020-02011-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":107,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2011"],"URL":"https:\/\/doi.org\/10.1186\/s13287-020-02011-z","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"14 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"519"}}